Cost ‘major barrier’ to access, patients lowering doses

Resounding support for subsidising GLP-1s for obesity treatment, PBS public consultation submissions show, with quality of medicines issues present Submissions from 491 consumers, 25 health professionals and 23 organisations to a Department of Health public consultation unanimously supported subsidising GLP-1s for obesity treatment, documents released today (17 March) reveal. The majority of consumer submissions were